Insulin Pen Market is expected to reach USD121.0 Million by 2023 | Becton Dickinson, Novo Nordisk, B. Braun Melsungen

Share this news:

Stay up-to-date with global Insulin Pen market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.

HTF Market Intelligence released a new research report of 111 pages on title 'Global Insulin Pen Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025' with detailed analysis, forecast and strategies. The study covers key regions that includes North America, Europe or Asia or Oceania [Australia and New Zealand] and important players such as Becton Dickinson (United States), Novo Nordisk (Denmark), B. Braun Melsungen (Germany), Spirit Healthcare (United Kingdom), Terumo Corporation (Japan), Ypsomed Holding AG (Switzerland), Dongbao Enterprise Group Co., Ltd. (China), Allison Medical (United States), UltiMed Inc. (United States), Shanghai Beipu Medical Co. Ltd. (China), HTL-STREFA (Poland).

Request a sample report @


Market Snapshot:
Insulin Pen is a pen used to inject insulin for the treatment of diabetes. The sleek design and compact size of insulin allows to easily deliver insulin anywhere by measuring and delivering from 0.5 to 80 units of insulin at a time. The maximum dose and the incremental amount vary depending upon the type of insulin pen being used. The insulin pen with its design allows accurate, simplified and convenient delivery. The insulin pen which are equipped and have auto shield needle may offer greater accuracy while injecting a dose. Insulin pens are easy to use particularly of elderly people having diabetes. Insulin pen has ability to fine tune and deliver highly accurate doses with portable, discreet and convenient nature of pen. Insulin pen have small and thin needle size which reduces the pain and fear for injecting insulin. It is one of the time saving device with memory features as well to show when and how much the last dose was. As the insulin pens are equipped with pre-filled and replaceable needle features, preference for the insulin pen continue to remain high in global market. These pens may be reusable or disposable. Disposable pen may contain a pre-filled insulin cartridge which is thrown away when the cartridge is empty. The reusable pen contain a replaceable insulin cartridge. Once the cartridge is empty it may be discarded and put the new cartridge for use.

According to AMA, the Global Insulin Pen market is expected to reach USD121.0 Million by 2023 growing at a CAGR of 10.9%.

Market Trend
Reusable insulin pens i.e. replaceable cartridge and other infusion devices are becoming technologically advanced

Market Drivers
Easy to carry as portable and available in compact size , shows accuracy in measuring and delivering insulin , Ease of usability , Provision of data regarding last dose , Replaceable needles & cartridge increases lifespan of product and Low cost

Increasing arrival of diabetes in various age groups , Inclination of the customers towards Time saving device due to busy life and Emergence of affordable devices for such a common disease like diabetes

The Players Covered in the Study are:

Becton Dickinson (United States)
Novo Nordisk (Denmark)
B. Braun Melsungen (Germany)
Spirit Healthcare (United Kingdom)
Terumo Corporation (Japan)
Ypsomed Holding AG (Switzerland)
Dongbao Enterprise Group Co., Ltd. (China)
Allison Medical (United States)
UltiMed Inc. (United States)
Shanghai Beipu Medical Co. Ltd. (China)

Regulatory Framework:
FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices. Food and Drug Administration (FDA) and World Health Organization (WHO) are providing the guidelines regarding the risk associated with medical device to ensure patient's safety and to check effectiveness of the devices.

Available Customization: List of players that can be included in the study on immediate basis are Owen Mumford (United States) , Jiangsu Delfu medical device (China) , Sanofi (France) and Eli Lilly (United States).

Make an enquiry before buying this Report @

Table of Contents

1 Market Overview

1.1 Insulin Pen Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico) United States Market States and Outlook (2013-2023) Canada Market States and Outlook (2013-2023) Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Germany Market States and Outlook (2013-2023) France Market States and Outlook (2013-2023) UK Market States and Outlook (2013-2023) Russia Market States and Outlook (2013-2023) Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) China Market States and Outlook (2013-2023) Japan Market States and Outlook (2013-2023) Korea Market States and Outlook (2013-2023) India Market States and Outlook (2013-2023) Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa Brazil Market States and Outlook (2013-2023) Egypt Market States and Outlook (2013-2023) Saudi Arabia Market States and Outlook (2013-2023) South Africa Market States and Outlook (2013-2023) Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1.1 Business Overview

2.1.2 Insulin Pen Type and Applications

2.1.3 Insulin Pen Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

View Detailed Table of Content @

Buy this report @

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand].

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Contact Info:
Email: Send Email
Organization: HTF market Intelligence Consulting Private Limited
Address: Unit No. 429, Parsonage Road, Edison, NJ USA - 08837
Phone: +1 (206) 317 1218

Release ID: 452707

Email: Send Email
Organization: HTF market Intelligence Consulting Private Limited
Address: Unit No. 429, Parsonage Road, Edison, NJ USA - 08837